AV Matveyenko, PC Butler - Diabetes Obes Metab, 2008 - interscience.wiley.com Regulation of blood glucose concentrations requires an adequate number of β-cells that respond
appropriately to blood glucose levels. β-Cell mass cannot yet be measured in humans in
vivo, necessitating autopsy studies, although both pre- and postmorbid changes may ... Cited by 9 - Related articles - All 2 versions
M Oikarinen, S Tauriainen, T Honkanen, K Vuori, P … - Diabetologia, 2008 - Springer Page 1. ARTICLE Analysis of pancreas tissue in a child positive for islet cell antibodies M.
Oikarinen & S. Tauriainen & T. Honkanen & K. Vuori & P. Karhunen & C. Vasama-Nolvi & S.
Oikarinen & C. Verbeke & GE Blair & I. Rantala & J. Ilonen & O. Simell & M. Knip & H. Hyöty ... Cited by 4 - Related articles - All 3 versions
- ►physiology.org AV Matveyenko, JD Veldhuis, PC … - American Journal of …, 2008 - Am Physiological Soc In health insulin is secreted in discrete insulin secretory bursts from pancreatic β-cells, collectively
referred to as β-cell mass. We sought to establish the relationship between β-cell mass, insulin
secretory-burst mass, and hepatic insulin clearance over a range of age-related insulin ... Cited by 3 - Related articles - All 4 versions
- ►snmjournals.org R Goland, M Freeby, R Parsey, Y Saisho, D … - Journal of Nuclear …, 2009 - Soc Nuclear Med Type 2 vesicular monoamine transporter (VMAT2), found in the brain, is also expressed by
β-cells of the pancreas in association with insulin. Preclinical experiments suggested that 11
C-dihydrotetrabenazine PET–measured VMAT2 binding might serve as a biomarker of ... Cited by 4 - Related articles - All 4 versions
C Hinault, J Hu, BF Maier, RG Mirmira, RN … - Diabetes Obes …, 2008 - interscience.wiley.com One of the major challenges for developmental biologists and investigators in the field of diabetes
over the last few decades has been to dissect the origin of pancreatic endocrine cells and to
accurately understand the mechanisms that regulate islet cell regeneration. While ... Cited by 3 - Related articles - All 2 versions
D Pipeleers, M Chintinne, B Denys, G … - Diabetes, Obesity …, 2008 - interscience.wiley.com Type 1 and type 2 diabetes have often been presented as disease forms that profoundly differ
in the presence and pathogenic significance of a reduced β-cell mass. We review evidence indicating
that the β-cell mass in type 1 diabetes is usually not decreased by at least 90% at clinical ... Cited by 3 - Related articles - All 2 versions
A Assmann, C Hinault, RN Kulkarni, JD … - Pediatric Diabetes, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 3 - Related articles - All 3 versions
MM Sachdeva, DA Stoffers - Molecular Endocrinology, 2009 - Endocrine Soc Type 2 diabetes results from pancreatic ß-cell failure in the setting of insulin resistance. This
model of disease progression has received recent support from the results of genome-wide association
studies that identify genes potentially regulating ß-cell growth and function as type 2 ... Cited by 2 - Related articles - All 3 versions
K Brennand, D Melton - J Cell Mol Med, 2009 - interscience.wiley.com The β-cells of the pancreas are responsible for insulin production and their destruction results
in type I diabetes. β-cell maintenance, growth, and regenerative repair is thought to occur
predominately, if not exclusively, through the replication of existing β-cells, not via an ... Cited by 1 - Related articles - All 3 versions
